Skip to main content


Counterfeit and falsified medicines (WP1185)

In 2008 in Ghana, 35% of anti-malarias were found to be substandard or counterfeit. To address this, companies that have produced fake products are being named and shamed. Through collaborative work, in 2011, this figure had reduced to below 5%. But this is just the start of what needs to be done.

Contributor is:

Stephen Opuni, Chief Executive, Food and Drugs Authority, Accra


Other podcasts in this series

Counterfeit and fake medicines with Duncan Learmouth, Senior Vice President, Developing Countries and Market Access, GlaxoSmithKline plc, Brentford


Want to find out more?

Sign up to our newsletter